AstraZeneca PLC is 223.8x more valuable than Damora Therapeutics, Inc. by market capitalization ($286.27 B vs $1.28 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DMRA | AZN |
|---|---|---|
| Market cap | $1.28 B | $286.27 B |
| US-listed rank | #2466 | #49 |
| Net income (latest FY) | -$209.84M | - |
| SEC filings | 329 | 1,004 |
AstraZeneca PLC is 223.8x more valuable than Damora Therapeutics, Inc. by market capitalization ($286.27 B vs $1.28 B).
Full pages: Damora Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.